to study whether the inhibition of excessive absorption of sodium might affect the course of lung disease in cystic fibrosis , we performed a double-blind , crossover trial comparing aerosolized amiloride ( 5 mmol per liter ; 3.5 ml four times daily ) , a sodium-channel blocker , with vehicle alone .
C0010674
cystic
C0002502
amiloride